Drug Type Stem cell therapy |
Synonyms JangoMed, Jango Org H2, Jango-Org H2 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Andropause | Preclinical | United States | 08 Jul 2024 | |
Osteoarthritis | Preclinical | United States | 08 Jul 2024 | |
Alzheimer Disease | Preclinical | United States | 12 Dec 2021 | |
Hypogonadism | Preclinical | United States | 12 Dec 2021 |